Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/12/2003US6605600 Diuretics
08/12/2003US6605599 Epothilone derivatives
08/12/2003US6605597 Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
08/12/2003US6605596 Indolocarbazole anticancer agents and methods of using them
08/12/2003US6605595 Higher antiparasitic activity
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605591 Treatment of subnormal bone mineral density
08/12/2003US6605467 Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine
08/12/2003US6605443 Drug screening for compound which disrupts Smad7 transforming growth-beta factor superfamily signal transduction inhibitory activity
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605424 Contacting with rhodopsin kinase- or beta adrenergic receptor kinase -containing sample; determination of receptor phosphorylation
08/12/2003US6605310 Calorically dense liquid oral supplement
08/12/2003US6605305 Antitumor agents; enzyme inhibitors
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/12/2003US6605302 Drug delivery device containing oseltamivir and an H1 antagonist
08/12/2003US6605301 Dispersible macrolide compounds and method for production thereof
08/12/2003US6605300 Oral pulsed dose drug delivery system
08/12/2003US6605299 Releasable linkage and compositions containing same
08/12/2003US6605298 Drug delivery
08/12/2003US6605297 Accelerating uncoupled respiration and proton leak of the inner membrane of mitochondria which are induced by uncoupling proteins usingcoupled isomerized highly unsaturated fatty acids
08/12/2003US6605295 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
08/12/2003US6605289 Topically administering composition consisting of water, stannous fluoride, and zinc gluconate in amount sufficient to prevent oxidation and hydrolysis of stannous ion for at least three months to animal afflicted with fungal infection
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003US6605282 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6605279 Nucleotide sequences coding preferential polypeptide for use in intensifying immunological response
08/12/2003US6605270 Iron-binding polymers for oral administration
08/12/2003US6605255 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body
08/12/2003US6604698 Forming a dispersion of solid particles of a milled substrate in a fluid carrier comprising providing large size milling media and small size milling media, a conglomerate of solid comprising a substrate to be milled, milling, separating
08/12/2003CA2418712A1 Non-peptide gnrh agents, pharmaceutical compositions, and methods for their use
08/12/2003CA2296373C Composition and method for treating penile erectile dysfunction
08/12/2003CA2286126C Pharmaceutical compositions
08/12/2003CA2277473C Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/12/2003CA2088702C Aminobenzoic acid derivatives
08/08/2003WO2002060922A2 Epoxyvibsanin b
08/08/2003CA2458220A1 Epoxyvibsanin b
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003065036A1 Method of identifying insulin secretion stimulating compounds, and the use of such compounds in treating insulin-secretion related disorders
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064663A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
08/07/2003WO2003064638A2 Elongase gene and method for producing polyunsaturated fatty acids
08/07/2003WO2003064626A2 Double-stranded oligonucleotides
08/07/2003WO2003064625A2 Oligonucleotide compositions with enhanced efficiency
08/07/2003WO2003064617A2 Pestalotiopsis microsporia isolates and compounds derived therefrom
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064456A1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
08/07/2003WO2003064455A2 Macrocyclic peptides active against the hepatitis c virus
08/07/2003WO2003064454A1 Fap-activated anti-tumor compounds
08/07/2003WO2003064451A2 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
08/07/2003WO2003064445A1 17-alpha-heterocyclic esters of androstane derivatives having anti-inflammatory activity
08/07/2003WO2003064444A1 Fractionation of phytosterol esters in oil
08/07/2003WO2003064443A2 New corticosteroids
08/07/2003WO2003064441A2 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003WO2003064440A1 Compounds that inhibit factor xa activity
08/07/2003WO2003064431A2 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
08/07/2003WO2003064430A1 Crystalline hydrochloride of 7-(((5-amino-1, 2, 4-thiadiazol-3-yl)(fluoromethoxyimino) acetyl) amino) -3- ((imino-1-piperazinylmethyl)methylhydrazono)-methyl-3-cephem-4-carboxylic acid
08/07/2003WO2003064426A1 N, n'-dimethylated n-confused porphyrins
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064424A2 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
08/07/2003WO2003064423A1 Aza-arylpiperazines
08/07/2003WO2003064422A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
08/07/2003WO2003064421A1 Aminopiperidine derivatives
08/07/2003WO2003064419A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/07/2003WO2003064418A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
08/07/2003WO2003064417A1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
08/07/2003WO2003064416A1 Heterocyclic tripeptides as hepatitis c inhibitors
08/07/2003WO2003064415A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003WO2003064413A1 Quinazoline compounds
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003064409A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003WO2003064407A2 Production of δ9 tetrahydrocannabinol
08/07/2003WO2003064406A1 Resistance-repellent retroviral protease inhibitors
08/07/2003WO2003064404A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
08/07/2003WO2003064403A1 Furanone derivatives
08/07/2003WO2003064402A1 Treatment of male sexual dysfunction
08/07/2003WO2003064398A1 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064395A1 Preventive or therapeutic agents for neurodegenerative diseases
08/07/2003WO2003064394A1 5-ring heterocycles used as antiviral agents
08/07/2003WO2003064392A1 Process for the manufacture of hmg-coa reductase inhibitors
08/07/2003WO2003064391A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
08/07/2003WO2003064389A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
08/07/2003WO2003064388A2 Process for the preparation of high purity perindopril and intermediates useful in the synthesis
08/07/2003WO2003064387A2 Substituted indoles as alpha-1 agonists
08/07/2003WO2003064383A2 Phosphorus-containing compounds & uses thereof
08/07/2003WO2003064378A2 Novel compounds that inhibit factor xa activity
08/07/2003WO2003064376A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/07/2003WO2003064375A1 New opioid derivative
08/07/2003WO2003064374A1 Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epileptic, neurological, and cns activity, and method for their preparation
08/07/2003WO2003064372A1 2-adamantylalkylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003064359A1 Bicyclic cb2 cannabinoid receptor ligands
08/07/2003WO2003063933A1 A method and system for treating an atrial arrhythmia
08/07/2003WO2003063927A2 Compositions and methods to treat gastrointestinal disorders
08/07/2003WO2003063924A1 Medical device for delivering biologically active material
08/07/2003WO2003063911A1 Decoy-containing pharmaceutical compositions and method of using the same
08/07/2003WO2003063910A2 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER
08/07/2003WO2003063908A1 Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
1 ... 5380 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 5398 5399 5400 ... 7860